002793 Stock Overview
Luoxin Pharmaceuticals Group Stock Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Luoxin Pharmaceuticals Group Stock Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥4.16 |
| 52 Week High | CN¥6.28 |
| 52 Week Low | CN¥3.22 |
| Beta | 0.50 |
| 11 Month Change | -12.79% |
| 3 Month Change | 12.13% |
| 1 Year Change | -32.14% |
| 33 Year Change | -58.97% |
| 5 Year Change | n/a |
| Change since IPO | -66.72% |
Recent News & Updates
Recent updates
Shareholder Returns
| 002793 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -2.6% | -1.5% | -2.1% |
| 1Y | -32.1% | -9.4% | 2.8% |
Return vs Industry: 002793 underperformed the CN Pharmaceuticals industry which returned -4.8% over the past year.
Return vs Market: 002793 underperformed the CN Market which returned 5.4% over the past year.
Price Volatility
| 002793 volatility | |
|---|---|
| 002793 Average Weekly Movement | 7.5% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 002793 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002793's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 3,388 | Zhenteng Liu | www.luoxin.cn |
Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, manufacture, and trading of drugs in China. The company provides antiviral, anti-infective, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic, analgesics, and anti-inflammatory APIs and intermediates.
Luoxin Pharmaceuticals Group Stock Co., Ltd. Fundamentals Summary
| 002793 fundamental statistics | |
|---|---|
| Market cap | CN¥4.42b |
| Earnings (TTM) | -CN¥697.00m |
| Revenue (TTM) | CN¥2.42b |
1.8x
P/S Ratio-6.3x
P/E RatioIs 002793 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002793 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.42b |
| Cost of Revenue | CN¥1.45b |
| Gross Profit | CN¥967.61m |
| Other Expenses | CN¥1.66b |
| Earnings | -CN¥697.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.66 |
| Gross Margin | 40.01% |
| Net Profit Margin | -28.82% |
| Debt/Equity Ratio | 86.0% |
How did 002793 perform over the long term?
See historical performance and comparison